Literature DB >> 23233383

Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke.

Chelsea S Kidwell1, Max Wintermark, Deidre A De Silva, Timothy J Schaewe, Reza Jahan, Sidney Starkman, Tudor Jovin, Jason Hom, Mouhammad Jumaa, Jeffrie Schreier, Jeffrey Gornbein, David S Liebeskind, Jeffry R Alger, Jeffrey L Saver.   

Abstract

BACKGROUND AND
PURPOSE: Objective imaging methods to identify optimal candidates for late recanalization therapies are needed. The study goals were (1) to develop magnetic resonance imaging (MRI) and computed tomography (CT) multiparametric, voxel-based predictive models of infarct core and penumbra in acute ischemic stroke patients, and (2) to develop patient-level imaging criteria for favorable penumbral pattern based on good clinical outcome in response to successful recanalization.
METHODS: An analysis of imaging and clinical data was performed on 2 cohorts of patients (one screened with CT, the other with MRI) who underwent successful treatment for large vessel, anterior circulation stroke. Subjects were divided 2:1 into derivation and validation cohorts. Pretreatment imaging parameters independently predicting final tissue infarct and final clinical outcome were identified.
RESULTS: The MRI and CT models were developed and validated from 34 and 32 patients, using 943 320 and 1 236 917 voxels, respectively. The derivation MRI and 2-branch CT models had an overall accuracy of 74% and 80%, respectively, and were independently validated with an accuracy of 71% and 79%, respectively. The imaging criteria of (1) predicted infarct core ≤90 mL and (2) ratio of predicted infarct tissue within the at-risk region ≤70% identified patients as having a favorable penumbral pattern with 78% to 100% accuracy.
CONCLUSIONS: Multiparametric voxel-based MRI and CT models were developed to predict the extent of infarct core and overall penumbral pattern status in patients with acute ischemic stroke who may be candidates for late recanalization therapies. These models provide an alternative approach to mismatch in predicting ultimate tissue fate.

Entities:  

Mesh:

Year:  2012        PMID: 23233383      PMCID: PMC3558033          DOI: 10.1161/STROKEAHA.112.670034

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

1.  Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial.

Authors:  Chelsea S Kidwell; Reza Jahan; Jeffry R Alger; Timothy J Schaewe; Judy Guzy; Sidney Starkman; Robert Elashoff; Jeffrey Gornbein; Val Nenov; Jeffrey L Saver
Journal:  Int J Stroke       Date:  2012-09-13       Impact factor: 5.266

2.  Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements.

Authors:  B D Murphy; A J Fox; D H Lee; D J Sahlas; S E Black; M J Hogan; S B Coutts; A M Demchuk; M Goyal; R I Aviv; S Symons; I B Gulka; V Beletsky; D Pelz; V Hachinski; R Chan; T-Y Lee
Journal:  Stroke       Date:  2006-06-08       Impact factor: 7.914

3.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

4.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

Authors:  Stephen M Davis; Geoffrey A Donnan; Mark W Parsons; Christopher Levi; Kenneth S Butcher; Andre Peeters; P Alan Barber; Christopher Bladin; Deidre A De Silva; Graham Byrnes; Jonathan B Chalk; John N Fink; Thomas E Kimber; David Schultz; Peter J Hand; Judith Frayne; Graeme Hankey; Keith Muir; Richard Gerraty; Brian M Tress; Patricia M Desmond
Journal:  Lancet Neurol       Date:  2008-02-28       Impact factor: 44.182

5.  Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

Authors:  Werner Hacke; Anthony J Furlan; Yasir Al-Rawi; Antoni Davalos; Jochen B Fiebach; Franz Gruber; Markku Kaste; Leslie J Lipka; Salvador Pedraza; Peter A Ringleb; Howard A Rowley; Dietmar Schneider; Lee H Schwamm; Joaquin Serena Leal; Mariola Söhngen; Phil A Teal; Karin Wilhelm-Ogunbiyi; Max Wintermark; Steven Warach
Journal:  Lancet Neurol       Date:  2008-12-25       Impact factor: 44.182

6.  White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study.

Authors:  Blake D Murphy; Allan J Fox; Donald H Lee; Demetrios J Sahlas; Sandra E Black; Matthew J Hogan; Shelagh B Coutts; Andrew M Demchuk; Mayank Goyal; Richard I Aviv; Sean Symons; Irene B Gulka; Vadim Beletsky; David Pelz; Richard K Chan; Ting-Yim Lee
Journal:  Radiology       Date:  2008-04-18       Impact factor: 11.105

7.  Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

Authors:  Nils Wahlgren; Niaz Ahmed; Niclas Eriksson; Franz Aichner; Erich Bluhmki; Antoni Dávalos; Terttu Erilä; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Martin Köhrmann; Vincent Larrue; Kennedy R Lees; Thomas Machnig; Risto O Roine; Danilo Toni; Geert Vanhooren
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

8.  Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients.

Authors:  Wataru Kakuda; Maarten G Lansberg; Vincent N Thijs; Stephanie M Kemp; Roland Bammer; Lawrence R Wechsler; Michael E Moseley; Michael P Marks; Michael P Parks; Gregory W Albers
Journal:  J Cereb Blood Flow Metab       Date:  2008-01-09       Impact factor: 6.200

9.  Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: predictive value of infarct core size on clinical outcome.

Authors:  R Gasparotti; M Grassi; D Mardighian; M Frigerio; M Pavia; R Liserre; M Magoni; L Mascaro; A Padovani; A Pezzini
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-22       Impact factor: 3.825

10.  How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET.

Authors:  Masashi Takasawa; P Simon Jones; Joseph V Guadagno; Soren Christensen; Tim D Fryer; Sally Harding; Jonathan H Gillard; Guy B Williams; Franklin I Aigbirhio; Elizabeth A Warburton; Leif Østergaard; Jean-Claude Baron
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

View more
  26 in total

1.  Defining the ischemic penumbra using magnetic resonance oxygen metabolic index.

Authors:  Hongyu An; Andria L Ford; Yasheng Chen; Hongtu Zhu; Rosana Ponisio; Gyanendra Kumar; Amirali Modir Shanechi; Naim Khoury; Katie D Vo; Jennifer Williams; Colin P Derdeyn; Michael N Diringer; Peter Panagos; William J Powers; Jin-Moo Lee; Weili Lin
Journal:  Stroke       Date:  2015-02-26       Impact factor: 7.914

2.  Multimodal imaging in acute ischemic stroke.

Authors:  William A Copen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

Review 3.  Physiologic imaging in acute stroke: Patient selection.

Authors:  Clinton D Morgan; Marcus Stephens; Scott L Zuckerman; Magarya S Waitara; Peter J Morone; Michael C Dewan; J Mocco
Journal:  Interv Neuroradiol       Date:  2015-06-10       Impact factor: 1.610

4.  Multimodal MR imaging model to predict tumor infiltration in patients with gliomas.

Authors:  Christopher R Durst; Prashant Raghavan; Mark E Shaffrey; David Schiff; M Beatriz Lopes; Jason P Sheehan; Nicholas J Tustison; James T Patrie; Wenjun Xin; W Jeff Elias; Kenneth C Liu; Greg A Helm; A Cupino; Max Wintermark
Journal:  Neuroradiology       Date:  2013-12-15       Impact factor: 2.804

5.  Apparent Diffusion Coefficient Signal Intensity Ratio Predicts the Effect of Revascularization on Ischemic Cerebral Edema.

Authors:  Matthew B Bevers; Thomas W K Battey; Ann-Christin Ostwaldt; Reza Jahan; Jeffrey L Saver; W Taylor Kimberly; Chelsea S Kidwell
Journal:  Cerebrovasc Dis       Date:  2018-03-13       Impact factor: 2.762

6.  Three-dimensional black-blood contrast-enhanced MRI improves detection of intraluminal thrombi in patients with acute ischaemic stroke.

Authors:  Won Jang; Hyo Sung Kwak; Gyung Ho Chung; Seung Bae Hwang
Journal:  Eur Radiol       Date:  2018-03-19       Impact factor: 5.315

7.  Multivariate dynamic prediction of ischemic infarction and tissue salvage as a function of time and degree of recanalization.

Authors:  André Kemmling; Fabian Flottmann; Nils Daniel Forkert; Jens Minnerup; Walter Heindel; Goetz Thomalla; Bernd Eckert; Michael Knauth; Marios Psychogios; Soenke Langner; Jens Fiehler
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

8.  A trial of imaging selection and endovascular treatment for ischemic stroke.

Authors:  Chelsea S Kidwell; Reza Jahan; Jeffrey Gornbein; Jeffry R Alger; Val Nenov; Zahra Ajani; Lei Feng; Brett C Meyer; Scott Olson; Lee H Schwamm; Albert J Yoo; Randolph S Marshall; Philip M Meyers; Dileep R Yavagal; Max Wintermark; Judy Guzy; Sidney Starkman; Jeffrey L Saver
Journal:  N Engl J Med       Date:  2013-02-08       Impact factor: 91.245

Review 9.  Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions.

Authors:  Jason Tarpley; Dan Franc; Aaron P Tansy; David S Liebeskind
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

10.  Multiparametric classification of sub-acute ischemic stroke recovery with ultrafast diffusion, 23 Na, and MPIO-labeled stem cell MRI at 21.1 T.

Authors:  Avigdor Leftin; Jens T Rosenberg; Xuegang Yuan; Teng Ma; Samuel C Grant; Lucio Frydman
Journal:  NMR Biomed       Date:  2019-12-03       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.